View Financial HealthCENOTEC 配当と自社株買い配当金 基準チェック /06CENOTEC配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesValuation Update With 7 Day Price Move • 11hInvestor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩1,326, the stock trades at a trailing P/E ratio of 28x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 36% over the past three years.New Risk • Mar 20New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.1x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Share price has been highly volatile over the past 3 months (18% average weekly change). Minor Risk Market cap is less than US$100m (₩60.8b market cap, or US$40.5m).お知らせ • Mar 04CENOTEC Co., Ltd., Annual General Meeting, Mar 24, 2026CENOTEC Co., Ltd., Annual General Meeting, Mar 24, 2026, at 09:00 Tokyo Standard Time. Location: auditorium, 1256-40, hamma-daero, gaya-eup, haman-gun, gyeongsangnam-do, South Korea分析記事 • Jan 22Optimistic Investors Push CENOTEC Co., Ltd. (KOSDAQ:222420) Shares Up 38% But Growth Is LackingThe CENOTEC Co., Ltd. ( KOSDAQ:222420 ) share price has done very well over the last month, posting an excellent gain...New Risk • Jan 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.3% average weekly change). Market cap is less than US$100m (₩52.3b market cap, or US$35.6m).分析記事 • Jan 20CENOTEC (KOSDAQ:222420) Is Doing The Right Things To Multiply Its Share PriceDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...Reported Earnings • Nov 14Third quarter 2025 earnings released: EPS: ₩6.00 (vs ₩16.00 loss in 3Q 2024)Third quarter 2025 results: EPS: ₩6.00 (up from ₩16.00 loss in 3Q 2024). Revenue: ₩10.0b (up 24% from 3Q 2024). Net income: ₩264.3m (up ₩1.01b from 3Q 2024). Profit margin: 2.6% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has fallen by 24% per year, which means it is performing significantly worse than earnings.お知らせ • Jun 13CENOTEC Co., Ltd. announced that it has received KRW 8 billion in fundingOn June 12, 2025, CENOTEC Co., Ltd. closed the transaction.お知らせ • Jun 11CENOTEC Co., Ltd. announced that it expects to receive KRW 8 billion in fundingCENOTEC Co., Ltd. announced a private placemen to issue 2% Series 4 Unsecured Private Placement Convertible Bonds due June 12, 2029 for gross proceeds of KRW 8,000,000,000 on June 10, 2025. The transaction will include participation from new investors Synergy IB Win-Win Innovation New Technology Fund KRW 3,000,000,000, Synergy-Premier Mezzanine Blind No. 1 New Technology Business Investment Fund KRW 2,500,000,000, Synergy NH Mezzanine Blind 2 New Technology Business Fund KRW 1,000,000,000 and Synergy IB Materials, Parts and Equipment No.14 New Technology Fund KRW 1,500,000,000. The transaction has been approved by shareholders, restricted to a hold period, expected to close on June 12, 2025, 100% convertible into 9,291,521 shares at a fixed conversion price of KRW 861 from June 12, 2026 to May 12, 2029, bears 2% coupon rate, 4% maturity rate and matures on June 12, 2029.お知らせ • Mar 05CENOTEC Co., Ltd., Annual General Meeting, Mar 25, 2025CENOTEC Co., Ltd., Annual General Meeting, Mar 25, 2025, at 09:00 Tokyo Standard Time. Location: auditorium, 1256-40, hamma-daero, gaya-eup, haman-gun, gyeongsangnam-do, South KoreaBoard Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • May 19CENOTEC Co., Ltd. announced that it has received KRW 17.5 billion in funding from Industrial Bank of Korea, Investment Arm, Samsung Securities Co. Ltd., Investment Arm, BNK Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Hanyang Securities Co., Ltd., Investment ArmOn May 18, 2021, CENOTEC Co., Ltd. (KOSDAQ:A222420) closed the transaction.Is New 90 Day High Low • Feb 25New 90-day high: ₩2,665The company is up 31% from its price of ₩2,035 on 27 November 2020. The South Korean market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period.Is New 90 Day High Low • Jan 20New 90-day high: ₩2,275The company is up 14% from its price of ₩1,990 on 22 October 2020. The South Korean market is up 28% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 38% over the same period.Is New 90 Day High Low • Jan 04New 90-day high: ₩2,240The company is up 5.0% from its price of ₩2,140 on 06 October 2020. The South Korean market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.Is New 90 Day High Low • Nov 16New 90-day low: ₩1,890The company is down 10.0% from its price of ₩2,105 on 18 August 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.Is New 90 Day High Low • Oct 26New 90-day low: ₩1,910The company is down 19% from its price of ₩2,350 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.決済の安定と成長配当データの取得安定した配当: A222420の 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: A222420の配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場CENOTEC 配当利回り対市場A222420 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (A222420)n/a市場下位25% (KR)1.0%市場トップ25% (KR)3.9%業界平均 (Chemicals)1.3%アナリスト予想 (A222420) (最長3年)n/a注目すべき配当: A222420は最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: A222420は最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: A222420の 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: A222420が配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YKR 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 16:19終値2026/05/21 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋CENOTEC Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Valuation Update With 7 Day Price Move • 11hInvestor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩1,326, the stock trades at a trailing P/E ratio of 28x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 36% over the past three years.
New Risk • Mar 20New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.1x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Share price has been highly volatile over the past 3 months (18% average weekly change). Minor Risk Market cap is less than US$100m (₩60.8b market cap, or US$40.5m).
お知らせ • Mar 04CENOTEC Co., Ltd., Annual General Meeting, Mar 24, 2026CENOTEC Co., Ltd., Annual General Meeting, Mar 24, 2026, at 09:00 Tokyo Standard Time. Location: auditorium, 1256-40, hamma-daero, gaya-eup, haman-gun, gyeongsangnam-do, South Korea
分析記事 • Jan 22Optimistic Investors Push CENOTEC Co., Ltd. (KOSDAQ:222420) Shares Up 38% But Growth Is LackingThe CENOTEC Co., Ltd. ( KOSDAQ:222420 ) share price has done very well over the last month, posting an excellent gain...
New Risk • Jan 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.3% average weekly change). Market cap is less than US$100m (₩52.3b market cap, or US$35.6m).
分析記事 • Jan 20CENOTEC (KOSDAQ:222420) Is Doing The Right Things To Multiply Its Share PriceDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...
Reported Earnings • Nov 14Third quarter 2025 earnings released: EPS: ₩6.00 (vs ₩16.00 loss in 3Q 2024)Third quarter 2025 results: EPS: ₩6.00 (up from ₩16.00 loss in 3Q 2024). Revenue: ₩10.0b (up 24% from 3Q 2024). Net income: ₩264.3m (up ₩1.01b from 3Q 2024). Profit margin: 2.6% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has fallen by 24% per year, which means it is performing significantly worse than earnings.
お知らせ • Jun 13CENOTEC Co., Ltd. announced that it has received KRW 8 billion in fundingOn June 12, 2025, CENOTEC Co., Ltd. closed the transaction.
お知らせ • Jun 11CENOTEC Co., Ltd. announced that it expects to receive KRW 8 billion in fundingCENOTEC Co., Ltd. announced a private placemen to issue 2% Series 4 Unsecured Private Placement Convertible Bonds due June 12, 2029 for gross proceeds of KRW 8,000,000,000 on June 10, 2025. The transaction will include participation from new investors Synergy IB Win-Win Innovation New Technology Fund KRW 3,000,000,000, Synergy-Premier Mezzanine Blind No. 1 New Technology Business Investment Fund KRW 2,500,000,000, Synergy NH Mezzanine Blind 2 New Technology Business Fund KRW 1,000,000,000 and Synergy IB Materials, Parts and Equipment No.14 New Technology Fund KRW 1,500,000,000. The transaction has been approved by shareholders, restricted to a hold period, expected to close on June 12, 2025, 100% convertible into 9,291,521 shares at a fixed conversion price of KRW 861 from June 12, 2026 to May 12, 2029, bears 2% coupon rate, 4% maturity rate and matures on June 12, 2029.
お知らせ • Mar 05CENOTEC Co., Ltd., Annual General Meeting, Mar 25, 2025CENOTEC Co., Ltd., Annual General Meeting, Mar 25, 2025, at 09:00 Tokyo Standard Time. Location: auditorium, 1256-40, hamma-daero, gaya-eup, haman-gun, gyeongsangnam-do, South Korea
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • May 19CENOTEC Co., Ltd. announced that it has received KRW 17.5 billion in funding from Industrial Bank of Korea, Investment Arm, Samsung Securities Co. Ltd., Investment Arm, BNK Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Hanyang Securities Co., Ltd., Investment ArmOn May 18, 2021, CENOTEC Co., Ltd. (KOSDAQ:A222420) closed the transaction.
Is New 90 Day High Low • Feb 25New 90-day high: ₩2,665The company is up 31% from its price of ₩2,035 on 27 November 2020. The South Korean market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Jan 20New 90-day high: ₩2,275The company is up 14% from its price of ₩1,990 on 22 October 2020. The South Korean market is up 28% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 38% over the same period.
Is New 90 Day High Low • Jan 04New 90-day high: ₩2,240The company is up 5.0% from its price of ₩2,140 on 06 October 2020. The South Korean market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.
Is New 90 Day High Low • Nov 16New 90-day low: ₩1,890The company is down 10.0% from its price of ₩2,105 on 18 August 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Oct 26New 90-day low: ₩1,910The company is down 19% from its price of ₩2,350 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.